Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$431M |
| 2 |
Truist Financial
TFC
|
+$346M |
| 3 |
Alibaba
BABA
|
+$238M |
| 4 |
ServiceNow
NOW
|
+$228M |
| 5 |
Corteva
CTVA
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$875M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$395M |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$340M |
| 4 |
Oracle
ORCL
|
+$197M |
| 5 |
Apple
AAPL
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.13% |
| 2 | Financials | 14.48% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Dynatrace
DT
$14.7B
| $9.23M | ﹤0.01% |
364,916
+106,761
| +41% | +$2.34M |
|
|
FLXN
2227
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $9.23M | ﹤0.01% |
445,895
-14,594
| -3% | -$246K |
|
|
CUK
2228
DELISTED
Carnival PLC
CUK
| $9.22M | ﹤0.01% |
191,524
-10,251
| -5% | -$433K |
|
|
EB
2229
DELISTED
Eventbrite
EB
| $9.18M | ﹤0.01% |
455,091
-8,638
| -2% | -$165K |
|
2230
iShares Russell Mid-Cap Value ETF
IWS
$16.1B
| $9.17M | ﹤0.01% |
96,756
+2,724
| +3% | +$249K |
|
|
ATRS
2231
DELISTED
Antares Pharma, Inc.
ATRS
| $9.14M | ﹤0.01% |
1,945,617
-288,342
| -13% | -$1.18M |
|
|
IMGN
2232
DELISTED
Immunogen Inc
IMGN
| $9.14M | ﹤0.01% |
1,790,481
-77,510
| -4% | -$263K |
|
2233
Omeros
OMER
$1.26B
| $9.12M | ﹤0.01% |
647,426
+2,074
| +0.3% | +$30.4K |
|
2234
Pacific Biosciences
PACB
$357M
| $9.12M | ﹤0.01% |
1,774,611
-56,013
| -3% | -$285K |
|
2235
Veeco
VECO
$3.28B
| $9.1M | ﹤0.01% |
619,520
-19,247
| -3% | -$262K |
|
2236
Ichor Holdings
ICHR
$2.67B
| $9.07M | ﹤0.01% |
272,651
-2,325
| -0.8% | -$69.3K |
|
|
JAG
2237
DELISTED
Jagged Peak Energy Inc.
JAG
| $9.05M | ﹤0.01% |
1,066,545
-277,005
| -21% | -$2.02M |
|
2238
James Hardie Industries
JHX
$17.9B
| $9.03M | ﹤0.01% |
459,855
+8,420
| +2% | +$156K |
|
|
YMAB
2239
DELISTED
Y-mAbs Therapeutics
YMAB
| $9.03M | ﹤0.01% |
288,898
+41,572
| +17% | +$1.23M |
|
2240
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.4B
| $9.03M | ﹤0.01% |
779,667
+32,887
| +4% | +$319K |
|
2241
QuinStreet
QNST
$1.19B
| $9M | ﹤0.01% |
587,967
-58,256
| -9% | -$831K |
|
2242
Origin Bancorp
OBK
$1.69B
| $8.98M | ﹤0.01% |
237,221
+6,600
| +3% | +$231K |
|
2243
Teck Resources
TECK
$31.3B
| $8.97M | ﹤0.01% |
516,657
-15,022
| -3% | -$245K |
|
2244
The RMR Group
RMR
$346M
| $8.92M | ﹤0.01% |
195,529
-6,345
| -3% | -$294K |
|
2245
Weis Markets
WMK
$1.77B
| $8.91M | ﹤0.01% |
220,140
-1,740
| -0.8% | -$67.3K |
|
2246
Horizon Bancorp
HBNC
$1.05B
| $8.91M | ﹤0.01% |
469,028
-14,105
| -3% | -$259K |
|
2247
Descartes Systems
DSGX
$6.62B
| $8.91M | ﹤0.01% |
208,567
+4,712
| +2% | +$192K |
|
|
VCRA
2248
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $8.86M | ﹤0.01% |
426,773
-40,527
| -9% | -$889K |
|
2249
iQIYI
IQ
$1.31B
| $8.81M | ﹤0.01% |
417,261
+41,231
| +11% | +$758K |
|
2250
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
| $8.8M | ﹤0.01% |
139,756
-36
| -0% | -$2.22K |
|
Similar funds
Northern Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Northern Trust held 4,386 positions worth $447B, up 7% from $418B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Northern Trust's Q4 2019 filing shows 134 new, 1,479 increased, 2,453 reduced and 124 closed positions. Its largest new stake was Envista: 706,517 shares worth $20.9M. The largest sale was Celgene Corp, an estimated $875M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2019 buy was Envista: 706,517 shares worth $20.9M.
- Northern Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $431M increase.
- Northern Trust's biggest Q4 2019 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $395M.
- Northern Trust fully exited Celgene Corp in Q4 2019, selling an estimated $875M.
- Northern Trust's ten largest holdings make up 17% of its $447B portfolio in Q4 2019.
- Northern Trust opened 134 new positions and closed 124 in Q4 2019.
- Northern Trust's portfolio value rose 7% quarter-over-quarter to $447B.
Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.